<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJCM</journal-id><journal-title-group><journal-title>International Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2158-284X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijcm.2015.66055</article-id><article-id pub-id-type="publisher-id">IJCM-57463</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Serum Resistin Level and Polymorphonuclear Leukocytes Dysfunctions in Children on Regular Hemodialysis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>aha</surname><given-names>Yousef Zein</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Manal</surname><given-names>Abdel-Salam</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Iman</surname><given-names>Abdel-Aziz</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Naglaa</surname><given-names>Fathy Mohamed</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Pediatrics, Faculty of Medicine (Girls), Al-Azhar University, Cairo, Egypt</addr-line></aff><aff id="aff2"><addr-line>Department of Clinical and Chemical Pathology, Theodor Bilharz Research Institute, Cairo, Egypt</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>manal24969@gmail.com(MA)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>06</month><year>2015</year></pub-date><volume>06</volume><issue>06</issue><fpage>423</fpage><lpage>430</lpage><history><date date-type="received"><day>4</day>	<month>May</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>21</month>	<year>June</year>	</date><date date-type="accepted"><day>26</day>	<month>June</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   
   Resistin is a secretory adipocytoine, which is expressed mainly in humans by inflammatory cells especially macrophages. Resistin serum levels are elevated in end-stage renal diseases of people having an increased risk of infections as a result of impaired polymorphonuclear leukocytes (PMNLs) functions. Objectives: To evaluate neutrophil functions (phagocytosis and oxidative burst) in children with end-stage renal disease (ESRD) on regular hemodialysis and to shed light on the contribution of resistin on neutrophil functions. Patients and Methods: The study included 40 children with ESRD on regular hemodialysis. Their ages ranged from 6 to 12 years, and they were selected from children attending the pediatric hemodialysis unit of AL-Zahraa Hospital, Al-Azher University during the period from October 2012 to December 2013. Another group of 40 apparently healthy children with matched age and sex with the patient group served as a control. Serum resistin, phagocytic index and nitro blue tetrazolium test (NBT%) were assessed in both groups. Results: There was a statistically more significant increase in resistin serum levels in cases than in controls; it was (3.25 &#177; 0.86 ng/ml) and (0.25 &#177; 0.16 ng/ml) respectively (P &lt; 0.01). On the other hand there was a statistically more significant decrease in neutrophil phagocytic index in cases than in controls; it was (2.57 &#177; 1.34) and (3.55 &#177; 0.74) respectively (P &lt; 0.01). Also it showed a statistically more significant decrease in NBT% in cases than in controls; it was (47.98 &#177; 16.38%) and (61.45 &#177; 13.17%) respectively (P &lt; 0.01). We found negative correlation between resistin serum level with phagocytic index and NBT%, while we found positive correlation between resistin serum level and hemodialysis duration. Conclusion: High resistin serum level in children with ESRD decreases phagocyte function and oxidative burst of PMNLs, and this is enhanced by the longer duration of hemodialysis. 
  
 
</p></abstract><kwd-group><kwd>Chronic Kidney Disease</kwd><kwd> Resistin</kwd><kwd> Dialysis</kwd><kwd> Polymorphonuclear Leukocytes</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Chronic kidney disease (CKD) is common, and its prevalence is increasing worldwide. Infection is a major cause of mortality in end-stage renal disease (ESRD) and hospitalization at all stages of CKD [<xref ref-type="bibr" rid="scirp.57463-ref1">1</xref>] .</p><p>The second commonest cause of death among patients with ESRD is septicemia and patients with ESRD are at an increased risk of death from infection compared to the general population [<xref ref-type="bibr" rid="scirp.57463-ref2">2</xref>] .</p><p>There is a wealth of evidence that disorders of both innate and adaptive immune systems contribute to an increased rate of infections in the course of ESRD. Functional abnormalities of monocytes, neutrophils, and dendritic cells are directly linked with infection risk in this patient population [<xref ref-type="bibr" rid="scirp.57463-ref3">3</xref>] .</p><p>Polymorphonuclear leukocytes (PMNLs) are professional phagocytes which engulf antibody-coated microbes [<xref ref-type="bibr" rid="scirp.57463-ref4">4</xref>] . They have many intra-cellular granules which contain bactericidal proteins. PMNs are the first line of defense against invading microbes and important players in inflammation [<xref ref-type="bibr" rid="scirp.57463-ref1">1</xref>] .</p><p>The adipose tissue has pleiotropic functions far beyond the storage of energy, and it secretes a number of hormones and cytokines, called adipokines, which have biological effects that impact health and disease. Adipokines are markedly elevated in the plasma of uremic patients, mainly due to decreased renal excretion. They have pluripotent signaling effects on inflammation/oxidative stress (e.g. leptin, adiponectin, resistin) [<xref ref-type="bibr" rid="scirp.57463-ref5">5</xref>] .</p><p>Resistin is a protein mediator secreted by adipocytes and macrophages within the adipose tissue [<xref ref-type="bibr" rid="scirp.57463-ref6">6</xref>] . In humans, resistin is essentially expressed in macrophages from white adipose tissue, rather than in human adipocytes per se [<xref ref-type="bibr" rid="scirp.57463-ref7">7</xref>] .</p><p>Conventional HD does not significantly decrease plasma resistin levels. Resistin was shown to interfere with the chemotactic movement and the oxidative burst of neutrophils at concentrations seen in uremia. As neutrophils are cells of the first-line nonspecific immune defense, resistin may contribute to the disturbed polymorphonuclear leukocyte (PMNLs) functions [<xref ref-type="bibr" rid="scirp.57463-ref8">8</xref>] and as a consequence to the increased risk of infections in uremic patients [<xref ref-type="bibr" rid="scirp.57463-ref5">5</xref>] .</p><p>We aimed to shed light on the contribution of resistin on neutrophil functions including phagocytosis and oxidative burst in children with end-stage renal disease (ESRD) on regular hemodialysis.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>The study is a cross sectional comparative study. It was carried out on 80 children, their ages ranged from 4 - 16 years during the period from October 2012 to December 2013. They were divided into two groups: Group I: (case group): included 40 with ESRD (GFR 15 ml/min/1.73) on regular hemodialysis, at least more than 3 months at the time of the study for 4 hours/setting, 3 times weekly with low flux polysulphone membrane by Fresenius machine. They were selected from the hemodialysis unit of Al-Zahraa hospital, Al-Azhar University, they were 21 female and 19 male. The most common cause of ESRD in patients group was FSGS in 20% followed by unknown (17.5%) and polycystic kidney (17.5%).</p><p>Group II: (control group) included 40 apparently healthy children matched age and sex with group I, they were selected from patients relatives. Children with; primary immune deficiency, acute and chronic infections children receiving medications (antibiotics, cytotoxic drugs, immunosuppressive) were excluded from the study. Patients were subjected to full history taking; etiology, onset of CKD and the duration of hemodialysis, history of medications and recurrent infection, including (cellulites, gingivitis, pneumonia, UTI, otitis media) and laboratory investigations for both groups.</p><p>Informed consent was obtained from the participating parents in adherence with the guidelines of the ethical committee of AL-Zahraa hospital, AL-Azhar University, Cairo, Egypt.</p><sec id="s2_1"><title>2.1. Blood Sample Collection</title><p>5 ml venous blood samples were withdrawn.</p><p>・ 2 ml on EDTA blood for CBC.</p><p>・ 3 ml of the samples were put in a plain tube and left to clot and sera were separated for BUN, serum creatinine and CRP.</p><p>・ Another portion of the serum samples were stored frozen at-20 c after careful labeling till the time of resistin assay.</p><p>4 ml of fresh venous blood samples on heparin for assessment of neutrophil functions (phagocytosis and oxidative burst).</p></sec><sec id="s2_2"><title>2.2. Assessment of Serum Resistin</title><p>Serum resistin level was measured by ELISA technique (using commercially available kit) supplied by Biovender research and diagnostic products.</p>Principal of the Procedure<p>This assay employs a quantitative sandwich enzyme immunoassay technique, which measures resistin in less than 5 hours.</p></sec><sec id="s2_3"><title>2.3. Assessment of Neutrophil Functions</title><sec id="s2_3_1"><title>2.3.1. Procedure</title><p>・ The fresh venous blood samples were left to sediment and the buffy coat was taken and washed with PBS (Phosphate Buffer Saline) centrifuged at 800 - 1000 rpm for 10 minutes.</p><p>・ Equal volumes from sediment + PBS + pooled serum was added to two tubes.</p><p>・ Candida albicans was added in the first tube and incubated at 37˚C for 30 minutes and 100 micron of NBT reagent in the second tube was added and incubated at room temperature for 15 minutes.</p><p>・ After incubation both samples were centrifuged for 5 minutes at 800 - 1000 rpm and slides was made and stained with Leisheman stain for 2 min, dilute with Gimesa stain for 5 minutes [<xref ref-type="bibr" rid="scirp.57463-ref9">9</xref>] .</p></sec><sec id="s2_3_2"><title>2.3.2. Estimation of Phagocytic Index and NBT%</title><p>Quantitate phagocytosis under oil-immersion microscopy, examining at least 200 cells and counting the number of internalized bacteria in each one. Calculate amount of phagocytosis according to the following formula:</p><p>1) Phagocytic index (PI) = (percentage of macrophages containing at least one bacterium) &#215; (mean number of bacteria per positive cell).</p><p>The normal reference range for phagocytic index is (2.4 - 4.5) [<xref ref-type="bibr" rid="scirp.57463-ref10">10</xref>] .</p><p>2) NBT% = (number of macrophages containing engulfed NBT/total number of counted macrophages) &#215; 100.</p><p>The normal reference range (47% - 85%).</p></sec></sec><sec id="s2_4"><title>2.4. Statistical Analysis</title><p>The data of collected questionnaire was entered and analyzed using SPSS 16.0 (Statistical Package for Social Sciences). Mean and standard deviation was given for normally distributed quantitative variables. Frequencies and percentages were given for qualitative variables. Two-independent sample t test was applied to observe group mean differences. Pearson correlation was applied to observe correlation between quantitative variables, P value of &lt;0.05 was considered statistically significant. Receiver operating characteristic curve (ROC) was used to assess the best cut off point with sensitivity, specificity, positive predictive value (+PV) and negative predictive value (−PV).</p></sec></sec><sec id="s3"><title>3. Results</title><p><xref ref-type="table" rid="table1">Table 1</xref>: showed that there is no statistically significant difference between patients group and the controls regarding total leukocyte counts (TLCs) and absolute neutrophil counts (ANCs), while there is a high statistically significant decrease in RBCs, Hb, Hct% and platelets counts in patients group than the controls. There was a statistical significant increase in serum creatinine and BUN in patients group compared to the controls. The same table showed that there was significant differences between patients group and the controls regarding CRP, we found that 24 (60.00%) out of 40 patients have CRP +ve, while all the controls have CRP −ve.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Comparison between patients group and the controls regarding age and routine laboratory data and CRP</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Variables</th><th align="center" valign="middle"  colspan="2"  >Control</th><th align="center" valign="middle"  colspan="2"  >Patients</th><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Independent t-test</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >(No. 40)</td><td align="center" valign="middle"  colspan="2"  >(No. 40)</td></tr><tr><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >t</td><td align="center" valign="middle" >p-value</td></tr><tr><td align="center" valign="middle" >Age years</td><td align="center" valign="middle" >10.95</td><td align="center" valign="middle" >&#177;2.86</td><td align="center" valign="middle" >10.01</td><td align="center" valign="middle" >&#177;3.27</td><td align="center" valign="middle" >1.287*</td><td align="center" valign="middle" >0.202</td></tr><tr><td align="center" valign="middle" >TLC &#215; 10<sup>3</sup> mm<sup>3</sup></td><td align="center" valign="middle" >7.64</td><td align="center" valign="middle" >1.47</td><td align="center" valign="middle" >8.25</td><td align="center" valign="middle" >3.82</td><td align="center" valign="middle" >−0.941</td><td align="center" valign="middle" >0.350</td></tr><tr><td align="center" valign="middle" >ANC &#215; 10<sup>3</sup> mm<sup>3</sup></td><td align="center" valign="middle" >4.8</td><td align="center" valign="middle" >0.99</td><td align="center" valign="middle" >4.52</td><td align="center" valign="middle" >2.72</td><td align="center" valign="middle" >0.602</td><td align="center" valign="middle" >0.549</td></tr><tr><td align="center" valign="middle" >RBCs &#215; 10<sup>6</sup> mm<sup>3</sup></td><td align="center" valign="middle" >4.69</td><td align="center" valign="middle" >0.43</td><td align="center" valign="middle" >3.47</td><td align="center" valign="middle" >0.76</td><td align="center" valign="middle" >8.827</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >Hb gm/dl</td><td align="center" valign="middle" >12.04</td><td align="center" valign="middle" >0.94</td><td align="center" valign="middle" >9.1</td><td align="center" valign="middle" >1.87</td><td align="center" valign="middle" >8.921</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >Hct%</td><td align="center" valign="middle" >36.37</td><td align="center" valign="middle" >2.55</td><td align="center" valign="middle" >28.19</td><td align="center" valign="middle" >4.79</td><td align="center" valign="middle" >9.537</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >Platelet &#215; 10<sup>3</sup> mm<sup>3</sup></td><td align="center" valign="middle" >290.25</td><td align="center" valign="middle" >51.25</td><td align="center" valign="middle" >247.18</td><td align="center" valign="middle" >87.61</td><td align="center" valign="middle" >2.684</td><td align="center" valign="middle" >0.009</td></tr><tr><td align="center" valign="middle" >ESR mm/first hour</td><td align="center" valign="middle" >12.78</td><td align="center" valign="middle" >4.25</td><td align="center" valign="middle" >51.68</td><td align="center" valign="middle" >31.32</td><td align="center" valign="middle" >−7.784</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >Creatinine mg/dl</td><td align="center" valign="middle" >0.35</td><td align="center" valign="middle" >0.11</td><td align="center" valign="middle" >7.86</td><td align="center" valign="middle" >2.08</td><td align="center" valign="middle" >22.796</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >Urea mg/dl</td><td align="center" valign="middle" >20.72</td><td align="center" valign="middle" >6.80</td><td align="center" valign="middle" >143.00</td><td align="center" valign="middle" >84.08</td><td align="center" valign="middle" >−7.248</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >CRP</td><td align="center" valign="middle" >no</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >no</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >X<sup>2</sup></td><td align="center" valign="middle" >p-value</td></tr><tr><td align="center" valign="middle" >+ve</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >100.00%</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >60.00%</td><td align="center" valign="middle"  rowspan="2"  >25.563</td><td align="center" valign="middle"  rowspan="2"  >0.000</td></tr><tr><td align="center" valign="middle" >−ve</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.00%</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >40.00%</td></tr></tbody></table></table-wrap><p>p &gt; 0.05: Non-significant; p &lt; 0.05: Significant; p &lt; 0.01: Highly significant.</p><p><xref ref-type="table" rid="table2">Table 2</xref>: showed that the most common type of recurrent infection in dialysis children was pneumonia 19 (47.5%) followed by UTI 13 (32.5%) while the least common infection type was otitis media (2.5%).</p><p><xref ref-type="table" rid="table3">Table 3</xref>: showed significant increase in resistin serum level in patient group compared to the controls, the same table showed significant decrease in phgocytic index and NTB% in patients group than in controls.</p><p><xref ref-type="table" rid="table4">Table 4</xref>: showed significant increase in resistin serum level in patients with CRP positive, while there was a statistically significant decrease in neutrophil phagocytic index and NBT% in patients with CRP positive.</p><p><xref ref-type="table" rid="table5">Table 5</xref>: showed significant positive correlation between resistin serum level with hemodialysis duration, while negative correlation between resistin with both neutrophil phagocytic index and NBT%.</p><p><xref ref-type="fig" rid="fig1">Figure 1</xref>: showed negative correlation between the duration of hemodialysis and phagocytic index.</p><p><xref ref-type="table" rid="table6">Table 6</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>: showed sensitivity and specificity of resistin serum level in predicting PMNLs dysfunctions in children with ESRD on regular hemodialysis; it revealed that resistin is 100% sensitive and specific in predicting PMNLs dysfunctions in children on regular hemodialysis.</p></sec><sec id="s4"><title>4. Discussion</title><p>The major concern of the present study is to assess resistin serum level in children with ESRD on regular hemodialysis and detect its reflection on PMNLs functions including phagocytosis and oxidative burst. We found highly significant increase in resistin level in patients group than the controls (p &lt; 0.01). Resistin levels have been found to be increased in chronic inflammatory conditions such as inflammatory bowel disease, rheumatoid arthritis, and uremia [<xref ref-type="bibr" rid="scirp.57463-ref11">11</xref>] .</p><p>Our results are in agreement with [<xref ref-type="bibr" rid="scirp.57463-ref8">8</xref>] who found that resistin level is higher in dialysis group than the controls ,also a study by [<xref ref-type="bibr" rid="scirp.57463-ref12">12</xref>] reported that increased serum resistin level in patients with ESRD. The study of [<xref ref-type="bibr" rid="scirp.57463-ref13">13</xref>] found that, the median serum resistin level was higher in children of uremia than controls in particular with a glomerular etiology compared with those with a non glomerular etiology (21.3 ng/mL vs 17.9 ng/mL; p = 0.03).</p><p>In our study we found significant decrease in neutrophil phagocytic function in patients group than in controls, which assessed by phagocyte index (PI) by measuring of phagocyte activity of candida albicans or bacterial cells ingested per phagocyte (neutrophil) during a limited period of incubation of a suspension of bacteria and phagocytes in serum. PMNLs are professional phagocytes which engulf antibody-coated and complement-coated microbes, damaged cells &amp; cellular debris. They have many intra-cellular granules which contain bactericidal</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Types of recurrent infections in patients group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Recurrent infections</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percent</th></tr></thead><tr><td align="center" valign="middle" >Pneumonia</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >47.5</td></tr><tr><td align="center" valign="middle" >UTI</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >32.5</td></tr><tr><td align="center" valign="middle" >Cellulites’</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >Tonsillitis</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >7.5</td></tr><tr><td align="center" valign="middle" >Otitis Media</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.5</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Comparison between patients group and the controls regarding resistin level, neutrophil phagocyic index and NBT%</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Variables</th><th align="center" valign="middle"  colspan="2"  >Controls</th><th align="center" valign="middle"  colspan="2"  >Patients</th><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Independent t-test</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >(No. 40)</td><td align="center" valign="middle"  colspan="2"  >(No. 40)</td></tr><tr><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >t</td><td align="center" valign="middle" >p-value</td></tr><tr><td align="center" valign="middle" >Resistin ng/ml</td><td align="center" valign="middle" >0.25</td><td align="center" valign="middle" >0.16</td><td align="center" valign="middle" >3.25</td><td align="center" valign="middle" >0.86</td><td align="center" valign="middle" >−21.681</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >Phagocytic index</td><td align="center" valign="middle" >3.55</td><td align="center" valign="middle" >0.74</td><td align="center" valign="middle" >2.57</td><td align="center" valign="middle" >1.34</td><td align="center" valign="middle" >4.055</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >NBT%</td><td align="center" valign="middle" >61.45</td><td align="center" valign="middle" >13.17</td><td align="center" valign="middle" >47.98</td><td align="center" valign="middle" >16.38</td><td align="center" valign="middle" >4.055</td><td align="center" valign="middle" >0.000</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> The relation between CRP and resistin level, phagocytic index and NBT%</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variables</th><th align="center" valign="middle"  colspan="2"  >Negative CRP</th><th align="center" valign="middle"  colspan="2"  >Positive CRP</th><th align="center" valign="middle"  colspan="2"  >Independent t-test</th></tr></thead><tr><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >SD</td><td align="center" valign="middle" >t</td><td align="center" valign="middle" >p-value</td></tr><tr><td align="center" valign="middle" >Resistin ng/ml</td><td align="center" valign="middle" >2.96</td><td align="center" valign="middle" >0.67</td><td align="center" valign="middle" >3.67</td><td align="center" valign="middle" >0.95</td><td align="center" valign="middle" >−2.8</td><td align="center" valign="middle" >0.008</td></tr><tr><td align="center" valign="middle" >Phagocytic index</td><td align="center" valign="middle" >3.05</td><td align="center" valign="middle" >1.37</td><td align="center" valign="middle" >1.84</td><td align="center" valign="middle" >0.94</td><td align="center" valign="middle" >3.087</td><td align="center" valign="middle" >0.004</td></tr><tr><td align="center" valign="middle" >NBT%</td><td align="center" valign="middle" >52.13</td><td align="center" valign="middle" >16.91</td><td align="center" valign="middle" >41.75</td><td align="center" valign="middle" >13.78</td><td align="center" valign="middle" >2.041</td><td align="center" valign="middle" >0.048</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Correlation between resistin level and some of clinical and laboratory parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variable</th><th align="center" valign="middle"  colspan="2"  >Resistin ng/ml</th></tr></thead><tr><td align="center" valign="middle" >r</td><td align="center" valign="middle" >p-value</td></tr><tr><td align="center" valign="middle" >Age (y)</td><td align="center" valign="middle" >−0.036</td><td align="center" valign="middle" >0.828</td></tr><tr><td align="center" valign="middle" >Duration of dialysis/month</td><td align="center" valign="middle" >0.351</td><td align="center" valign="middle" >0.027</td></tr><tr><td align="center" valign="middle" >Urea mg/dl</td><td align="center" valign="middle" >−0.011</td><td align="center" valign="middle" >0.947</td></tr><tr><td align="center" valign="middle" >Creatinine mg/dl</td><td align="center" valign="middle" >0.092</td><td align="center" valign="middle" >0.574</td></tr><tr><td align="center" valign="middle" >Phagocyte index</td><td align="center" valign="middle" >−0.569</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >NBT%</td><td align="center" valign="middle" >−0.569</td><td align="center" valign="middle" >0.000</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Correlation between resistin level and some of clinical and laboratory parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Best cut off point</th><th align="center" valign="middle" >AUC</th><th align="center" valign="middle" >Sensitivity</th><th align="center" valign="middle" >Specificity</th><th align="center" valign="middle" >+PV</th><th align="center" valign="middle" >−PV</th></tr></thead><tr><td align="center" valign="middle" >&gt;0.741</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >100.0</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Correlation between hemodialysis duration and phagocyte index</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/9-2101116x6.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Receiver operating characteristic (ROC) curve for resistin serum level in predicting PMNLs dysfunctions in hemodialysis children</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/9-2101116x7.png"/></fig><p>proteins. PMNLS are the first line of defense against invading microbes and important players in inflammation [<xref ref-type="bibr" rid="scirp.57463-ref3">3</xref>] . The susceptibility of CKD patients to infections as a result of defective phagocytosis is caused by a variety of factors, including uremic toxins such as resistin, iron overload, anemia of renal disease and dialyzer bioincompatiblity [<xref ref-type="bibr" rid="scirp.57463-ref14">14</xref>] .</p><p>Pneumonia is the commonest encountered infection type in the studied patients group, it is detected in (47%) followed by UTI (32.5%) and cellulites (10%), tonsillitis and otitis media represent (7.5%) and (2.5%) respectively. The susceptibility of CKD patients to infections as a result of defective phagocytosis caused by a variety of factors, including uremic toxins such as resistin, iron overload, anemia of renal disease and dialyzer bioincompatiblity [<xref ref-type="bibr" rid="scirp.57463-ref14">14</xref>] . Although clinical experience suggests that pneumonia occurs frequently in dialysis patients, its clinical epidemiology in that group remains poorly defined [<xref ref-type="bibr" rid="scirp.57463-ref15">15</xref>] .</p><p>Our results are in agreement with the results of [<xref ref-type="bibr" rid="scirp.57463-ref16">16</xref>] who reported that PMNLs ability to phagocyte is related to kidney function.</p><p>In our study there was a highly statistically significant decrease in oxidative burst of neutrophils in patients group than the controls which assessed by nitroblue tetrazolium test (NBT%). Nitroblue tetrazolelium test (NBT) is a test for assessment of oxidative function of neutrophils by measuring the activity of the NADPH oxidase system which generate superoxide and related oxygen intermediates which control bacterial and fungal infections [<xref ref-type="bibr" rid="scirp.57463-ref17">17</xref>] .</p><p>Our results are in agreement with. [<xref ref-type="bibr" rid="scirp.57463-ref18">18</xref>] who found that oxidative system of neutrophils are severely impaired in CKD patients and worsen progressively with the degree of renal failure. Ghobrial et al. [<xref ref-type="bibr" rid="scirp.57463-ref19">19</xref>] found that CKD is a state of oxidative stress and impaired oxidative functions.</p><p>In our study positive correlation between resistin level and the duration of hemodialysis (r = 0.351, p = 0.027), as resistin is an inflammatory cytokine, that was clearly associated with general inflammation and renal disease, it is increased with the longer duration of the disease and not improved by dialysis because conventional heamodialysis does not significantly decrease plasma resistin level [<xref ref-type="bibr" rid="scirp.57463-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.57463-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.57463-ref21">21</xref>] .</p><p>In our study there was a highly statistically significant increase in CRP level in patients group than the control group. In agreement with our results [<xref ref-type="bibr" rid="scirp.57463-ref19">19</xref>] who reported that children with CKD had higher percentages of positive CRP than the controls. Also in the same line [<xref ref-type="bibr" rid="scirp.57463-ref22">22</xref>] - [<xref ref-type="bibr" rid="scirp.57463-ref25">25</xref>] , they reported highly significant increased CRP levels in maintenance hemodialysis patients. Accordingly, we found that significant increase in serum resistin level with CRP positive than CRP negative patients, as well as significant decrease in the neutrophil functions (phagocytic index and nitroblue trtrazolium test NBT%) with CRP positive children than CRP negative, as CRP positive conditions are associated with inflammations and chronic infections that alter neutrophil functions. CRP and other acute phase proteins which are elevated in dialysis patients represent the single largest cause of mortality and morbidity in chronic renal failure patients due to impaired immunity.</p><p>In our study there was significant negative correlation between serum resistin level and neutrophil functions (phagocytosis and oxidative burst) as well as it is highly specific and sensitive in predicting PMNLs functions. Cohen et al. [<xref ref-type="bibr" rid="scirp.57463-ref8">8</xref>] found that high uremic resistin levels attenuate chemotaxis and the oxidative burst of PMNLs compared with normal levels, but they did not found a statistically significant difference as regard PMNL phagocytosis of opsonized E coli. The difference may be attributed to that [<xref ref-type="bibr" rid="scirp.57463-ref8">8</xref>] Cohen et al. [<xref ref-type="bibr" rid="scirp.57463-ref8">8</xref>] using PMNLs of healthy subjects and expose them to high levels of resistin.</p></sec><sec id="s5"><title>5. Conclusion</title><p>High resistin levels in children with ESRD decrease phagocytic function and oxidative burst of PMNLs and this effect is enhanced by the progression of the disease and longer duration of dialysis. We recommend targets for pharmacological intervention or new hemodialysis modalities to reduce resistin serum level, consequently improving PMNLs functions in these patients. Further studies are required in a large number of patients to determine the diagnostic implications of resistin in CKD patients.</p></sec><sec id="s6"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.57463-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Mayadas, T.N., Cellere, X. and Towell, C.A. (2014) The Multifaceted Functions of Neutrophils. Annual Review of Pathology: Mechanism of Disease, 9, 181-218. http://dx.doi.org/10.1146/annurev-pathol-020712-164023</mixed-citation></ref><ref id="scirp.57463-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">McDonald, B., Urrutia, R., Jenne, C.N. and Kubes, P. (2012) Intravascular Neutrophil Extracellular Traps Capture Bacteria from the Bloodstream during Sepsis. Cell Host Microbe, 12, 324-333. http://dx.doi.org/10.1016/j.chom.2012.06.011</mixed-citation></ref><ref id="scirp.57463-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Vaziri, N.D., Pahl, M.V., Crum, A. and Noris, K. (2012) Effect of Uremia on Structure and Function of Immune System. Journal of Renal Nutrition, 22, 149-156. http://dx.doi.org/10.1053/j.jrn.2011.10.020</mixed-citation></ref><ref id="scirp.57463-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Mocsai, A. (2013) Diverse Novel Functions of Neutrophils in Immunity, Inflammation and Beyond. Journal of Excremental Medicine, 210, 1283-1299. http://dx.doi.org/10.1084/jem.20122220</mixed-citation></ref><ref id="scirp.57463-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Teta, D. (2012) Adipokines as Uremic Toxins. Journal of Renal Nutrition, 22, 81-85. http://dx.doi.org/10.1053/j.jrn.2011.10.029</mixed-citation></ref><ref id="scirp.57463-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Korpela, L.S., Lehtimaki, L., Vuolteenaho, K., Nieminen, R., Saarelainen, H.K.S. and Moilanen, E. (2011) Adipokine Resistin Predicts Anti-Inflammatory Effect of Glucocorticoids in Asthma. Journal of Inflammation, 8, 12.http://dx.doi.org/10.1186/1476-9255-8-12</mixed-citation></ref><ref id="scirp.57463-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Patel, S.P. and Raju, P.A. (2013) Resistin in Serum and Gingival Cervical Fluid as a Marker of Periodontal Inflammation and Its Correlation with Single-Nucleotide Polymorphism in Human Resistin Gene at -420. Dental College and Research Institute, Bangalore, 192-197.</mixed-citation></ref><ref id="scirp.57463-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Cohen, G., Ilic, D., Raupachova, J. and Ho, W.H. (2008) Resistin Inhibits Essential Functions of Polymorphonuclear Leukocyte. Journal of Immunology, 181, 3761s-3768s. http://dx.doi.org/10.4049/jimmunol.181.6.3761</mixed-citation></ref><ref id="scirp.57463-ref9"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Muniz-Junqueira</surname><given-names> M.I</given-names></name>,<name name-style="western"><surname>. Pecanha</surname><given-names> L.M.</given-names></name>,<name name-style="western"><surname> de Silva-Filho</surname><given-names> V.L.</given-names></name>,<name name-style="western"><surname> de Almeida</surname><given-names> Cardoso</given-names></name>,<name name-style="western"><surname> M.C. and Tosta</surname><given-names> C.E. </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>Novel Micotechnique for Assessment of Postnatal Maturation of the Phagocytic Function of Neutrophil and Monocytes</article-title><source> Clinical and Diagnostic Laboratory Immunology</source><volume> 10</volume>,<fpage> 1096</fpage>-<lpage>1102</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.57463-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Carneir, O.V.M., Bezerra, A.C., Machado, M. do C., Guimaraes, M.D. and Muniz-Junqueira, M.I. (2012) Decreased Phagocytic Function in Neutrophils and Monocytes from Peripheral Blood in Periodontal Disease. Journal of Applied Oral Science, 20, 5. http://dx.doi.org/10.1590/s1678-77572012000500002</mixed-citation></ref><ref id="scirp.57463-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Almehed, K., d’Elia, H.F., Bokarewa, M. and Carlsten, H. (2008) Role of Resistin as a Marker of Inflammation in Systemic Lupus Erythematosus. Arthritis Research &amp; Therapy, 10, R15. http://dx.doi.org/10.1186/ar2366</mixed-citation></ref><ref id="scirp.57463-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Kader, N.A., Ali El-Din, F.A., Khatab, E.A.A. and Elabd, N.E. (2010) Does Plasma Resistin Level Have a Role in Predicting Inflammatory Bowel Disease Activity? Indian Journal of Gastroenterology, 29, 126-127.http://dx.doi.org/10.1007/s12664-010-0008-1</mixed-citation></ref><ref id="scirp.57463-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Nehus, E., Furth, S., Warady, B. and Mitsnefes, M. (2012) Correlates of Resistin in Children with Chronic Kidney Disease: The Chronic Kidney Disease in Children Cohort. The Journal of Pediatrics, 161, 276-280.http://dx.doi.org/10.1016/j.jpeds.2012.01.055</mixed-citation></ref><ref id="scirp.57463-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Zaza, G., Granata, S., Rascio, F., Pontrelli, P., Dell, M., Cox, S.H., Pertosa, G., Grandaliano, G. and Lupo, A. (2013) A Specific Immune Transcriptomic Profile Discriminates Chronic Kidney Disease Patients in Predialysis from Hemodialyzed Patients. BMC Medical Genomics, 6, 17. http://dx.doi.org/10.1186/1755-8794-6-17</mixed-citation></ref><ref id="scirp.57463-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Guo, H., Liu, J., Collins, A.J. and Foley, R.N. (2008) Pneumonia in Incident Dialysis Patients—The United States Renal Data System. Nephrology Dialysis Transplantation, 23, 680-686. http://dx.doi.org/10.1093/ndt/gfm474</mixed-citation></ref><ref id="scirp.57463-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Sardenberg, C., Suassuna, P., Andreoli, M.C., Watanabe, R., Dalboni, M.A., Manfredi, S.R., et al. (2006) Effects of Uraemia and Dialysis Modality on Polymorphonuclear Cell Apoptosis and Function. Nephrology Dialysis Transplantation, 21, 160-165. http://dx.doi.org/10.1093/ndt/gfi095</mixed-citation></ref><ref id="scirp.57463-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Gómez-Ochoa, P., Sabateb, D., Homedesb, J. and Ferrerc, L. (2012) Use of the Nitroblue Tetrazolium Reduction Test for the Evaluation of Domperidone Effects on the Neutrophilic Function of Healthy Dogs. Veterinary Immunology and Immunopathology, 146, 97-99. http://dx.doi.org/10.1016/j.vetimm.2012.01.018</mixed-citation></ref><ref id="scirp.57463-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Libetta, C., Sepe, V., Esposito, P. and Galli, F. (2011) Oxidative Stress and Inflammation: Implications in Uremia and Hemodialysis. Clinical Biochemistry, 44, 1189-1198. http://dx.doi.org/10.1016/j.clinbiochem.2011.06.988</mixed-citation></ref><ref id="scirp.57463-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Ghobrial, E.E., Mahfouz, N.N., Fathy, G.A., El Wakkad, A.A. and Sebaii, H.M. (2013) Oxidative Stress in Egyptian Heamodialysis Children. Iranian Journal of Kidney Diseases, 7, 485-491.</mixed-citation></ref><ref id="scirp.57463-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Nusken, K.D., Kratzsch, J., Wienholz, V., Stohr, W., Rascher, W. and Dotsch, J. (2006) Circulating Resistin Concentrations in Children Depend on Renal Function. Nephrology Dialysis Transplantation, 21, 107-112.http://dx.doi.org/10.1093/ndt/gfi084</mixed-citation></ref><ref id="scirp.57463-ref21"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mehdi</surname><given-names> W.A. </given-names></name>,<etal>et al</etal>. (<year>2011</year>)<article-title>Determination of Resistin and Several Antioxidants in Sera of Patients with Chronic Renal Failure</article-title><source> Australian Journal of Basic and Applied Sciences</source><volume> 5</volume>,<fpage> 196</fpage>-<lpage>203</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.57463-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Abraham, G., Sundaram, V., Sundaram, V., Mathew, M., Leslie, N. and Sathiah, V. (2009) C-Reactive Protein, a Valuable Predictive Marker in Chronic Kidney Disease. Saudi Journal of Kidney Diseases and Transplantation, 20, 811-815.</mixed-citation></ref><ref id="scirp.57463-ref23"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shroff</surname><given-names> R. </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>Monitoring Cardiovascular Risk Factors in Children on Dialysis</article-title><source> Peritoneal Dialysis International</source><volume> 29</volume>,<fpage> S173</fpage>-<lpage>S175</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.57463-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Gheissari, A., Kelishadi, R., Roomizadeh, P., Abedini, A., Haghjooy-Javanmard, S., Abtahi, S.H., et al. (2013) Chronic Kidney Disease Stages 3-5 in Iranian Children: Need for a School-Based Screening Strategy: The CASPIAN-III Study. International Journal of Preventive Medicine, 4, 95-101.</mixed-citation></ref><ref id="scirp.57463-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Ohtake, T., Ishioka, K., Honda, K., Oka, T., Maesato, K., Mano, T., Ikee, R., Moriya, H., Hidaka, S. and Kobayashi, S. (2010) Impact of Coronary Artery Calcification in Hemodialysis Patients and Association with Prognosis. Hemodialysis International, 14, 218-225. http://dx.doi.org/10.1111/j.1542-4758.2009.00423.x</mixed-citation></ref></ref-list></back></article>